| 000 | 01391 a2200361 4500 | ||
|---|---|---|---|
| 005 | 20250514200544.0 | ||
| 264 | 0 | _c20050803 | |
| 008 | 200508s 0 0 rus d | ||
| 022 | _a0869-8139 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aMazurov, A V | |
| 245 | 0 | 0 |
_a[Antiplatelet effects of glycoproteins IIb-IIIa antagonist monafram]. _h[electronic resource] |
| 260 |
_bRossiiskii fiziologicheskii zhurnal imeni I.M. Sechenova _cMay 2004 |
||
| 300 |
_a586-99 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Clinical Trial, Phase I; Clinical Trial, Phase II; English Abstract; Journal Article | ||
| 650 | 0 | 4 |
_aAntibodies, Monoclonal _xadministration & dosage |
| 650 | 0 | 4 |
_aCell Degranulation _xdrug effects |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aHemorrhage _xchemically induced |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHypersensitivity _xetiology |
| 650 | 0 | 4 |
_aImmunoglobulin Fab Fragments _xadministration & dosage |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aPlatelet Aggregation _xdrug effects |
| 650 | 0 | 4 |
_aPlatelet Glycoprotein GPIIb-IIIa Complex _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aThrombosis _xdrug therapy |
| 700 | 1 | _aPevzner, D V | |
| 700 | 1 | _aVlasik, T N | |
| 700 | 1 | _aRuda, M Ia | |
| 773 | 0 |
_tRossiiskii fiziologicheskii zhurnal imeni I.M. Sechenova _gvol. 90 _gno. 5 _gp. 586-99 |
|
| 999 |
_c15038162 _d15038162 |
||